To determine the effects of chronic nonocclusive coronary constriction on cardiac hemodynamics, structural integrity, and contractile protein enzyme activity, the left coronary artery was narrowed in rats, and measurements of ventricular performance, magnitude, and distribution of tissue damage and myofibrillar Mg2`and Ca2' myosin ATPase activities were evaluated 1 month later. In the presence of coronary artery stenosis averaging 58%, three levels of involvement of global cardiac performance were identified, and the rats were divided accordingly. In the first group, only left ventricular end-diastolic pressure (LVEDP) was increased; in the second group, LVEDP and left ventricular +dP/dt and/or -dP/dt were affected; and in the third group, LVEDP, left ventricular +dP/dt and -dP/dt, and right ventricular end-diastolic pressure were impaired. Thus, left ventricular moderate dysfunction, severe dysfunction, and failure occurred with coronary narrowing. On a structural basis, coronary constriction resulted in an ongoing process characterized by acute myocytolytic necrosis and foci of replacement fibrosis in different stages of healing. The number of these lesion profiles in the left ventricular myocardium increased 4.7-, 4.4-, and 8.3-fold in rats with moderate dysfunction, severe dysfunction, and failure, respectively. Biochemically, Mg2`-ATPase activity of myofibrils increased biventricularly when moderate dysfunction was present. However, this parameter decreased with the appearance of severe dysfunction, reaching control values in ventricular failure. Ca2' myosin ATPase activity was reduced in the left ventricle of rats with severe dysfunction and failure, whereas it was elevated in the right ventricle of rats with severe dysfunction. In conclusion, a fixed lesion of the left main coronary artery with a modest reduction in vessel luminal diameter generates a conditioned state of the heart characterized by a continuous loss of myocytes and replacement scarring, which, in combination with alterations in contractile protein enzyme activity, may be responsible for a number of abnormalities in cardiac dynamics ranging from moderate dysfunction to pump failure. (Circulation Research 1992;70:148-162) In coronary artery disease, the severity of the atherosclerotic involvement of the coronary vasculature has been considered the determining factor for the impairment of cardiac pump per-
pressure were impaired. Thus, left ventricular moderate dysfunction, severe dysfunction, and failure occurred with coronary narrowing. On a structural basis, coronary constriction resulted in an ongoing process characterized by acute myocytolytic necrosis and foci of replacement fibrosis in different stages of healing. The number of these lesion profiles in the left ventricular myocardium increased 4.7-, 4.4-, and 8.3-fold in rats with moderate dysfunction, severe dysfunction, and failure, respectively. Biochemically, Mg2`-ATPase activity of myofibrils increased biventricularly when moderate dysfunction was present. However, this parameter decreased with the appearance of severe dysfunction, reaching control values in ventricular failure. Ca2' myosin ATPase activity was reduced in the left ventricle of rats with severe dysfunction and failure, whereas it was elevated in the right ventricle of rats with severe dysfunction. In conclusion, a fixed lesion of the left main coronary artery with a modest reduction in vessel luminal diameter generates a conditioned state of the heart characterized by a continuous loss of myocytes and replacement scarring, which, in combination with alterations in contractile protein enzyme activity, may be responsible for a number of abnormalities in cardiac dynamics ranging from moderate dysfunction to pump failure. (Circulation Research 1992; 70:148-162) In coronary artery disease, the severity of the atherosclerotic involvement of the coronary vasculature has been considered the determining factor for the impairment of cardiac pump per-formance mediated by the reduction in coronary blood flow to the myocardium.1 If ischemia is the primary mechanism responsible for myocardial damage and depressed ventricular dynamics, large amounts of functioning tissue should be lost and replaced by areas of fibrosis throughout the ventricular wall. This condition is consistently found in humans2 and animal models34 in the presence of total occlusion of a major epicardial coronary artery and acute myocardial infarction in which a loss of 40-50% of myocytes is invariably characterized by overt cardiac failure. However, in nonocclusive coronary constriction in patients, similar lesions of the coronary arteries have been found to be associated with either congestive ischemic cardiomyopathy or with no signs of heart failure.5-7 At times, chronic stable or unstable angina is the only apparent clinical complaint. 8 Moreover, pathological findings in failing hearts indicate that moderate quantities of viable tissue have been lost, clearly at variance with the severity of the clinical picture.9,10 To account for the multiplicity and complexity of the human disease, it has been claimed that scattered sites of fibrosis within the myocardium may affect ventricular function more than an equivalent magnitude of tissue injury in a segmental fashion,9 such as myocardial infarction, although no evidence has been provided to support this conviction. Consistent with this belief, recent studies in rats analyzing the effects of acute11 and subacute12 nonocclusive coronary artery constriction have documented that severe ventricular dysfunction occurs with degrees of coronary narrowing not associated with reduced resting coronary blood flow but capable of inducing myocardial injury. In a fashion similar to that described in humans,9,10 the extent of tissue damage in rats was modest,1 ',12 raising questions of whether this limited amount of myocyte loss could ultimately be considered the etiologic mechanism responsible for cardiac failure. In addition, it remained unclear whether myocytolytic necrosis would continue with time and whether early ventricular decompensation was fully reversible or persisted during the healing process and long thereafter. Several cardiomyopathies associated with aging,13 with spontaneous14 or induced15 hypertension, and with a genetic defect16 have been shown to exhibit myocardial damage that is similar in characteristic and distribution to that found after coronary stenosis. In all these states, the appearance of myocyte loss and replacement scarring distinguishes the onset of the pathological process, which progressively deteriorates in spite of compensatory reactive growth adaptations in the unaffected cells.13,15 Moreover, the impairment of myocardial contractility has been seen to be paralleled by alterations in contractile protein enzyme activity,17-'9 which may partially explain the reduction in ventricular pump performance and the initiation of ventricular deadaptation and failure. Accordingly, coronary narrowing was produced in rats, and the functional, structural, and biochemical properties of the myocardium were investigated 1 month after surgery. This narrowing was performed to identify the critical events implicated in the occurrence and persistence of cardiac dysfunction and failure with nonocclusive constriction of a major epicardial coronary artery.
Materials and Methods
Coronary artery narrowing was performed in 34 male Sprague-Dawley rats at 2 months of age (Charles River Breeding Laboratories, North Wilmington, Mass.). Nine rats in this group died within 1-3 weeks after coronary constriction, mostly because of pulmonary edema. Ten sham-operated rats served as controls. All rats were killed 1 month after surgery.
Coronary Artery Narrowing
Under ether anesthesia, thoracotomy via the third left intercostal space was performed, the atrial appendage was elevated, the left coronary artery was located, and a suture was positioned around the vessel 1-2 mm from its origin. Subsequently, a probe of 275 ,um in diameter was held in contact with the wall of the exposed coronary artery. The entire vessel and the probe were ligated, and the probe was quickly removed.1'12 The chest was closed, and the rats were allowed to recover. Sham-operated control rats were treated similarly except that the ligature around the coronary artery was not tied. Since blood supply to the left ventricle in the rat heart is provided by the left descending and septal arteries with no evident circumflex artery, coronary constriction near its origin was expected to affect most of the left ventricle.20
Functional Measurements
Before death, the rats were anesthetized with chloral hydrate (300 mg/kg i.p.), and the external right carotid artery was cannulated with a microtip pressure transducer (model PR 249, Millar Instruments, Houston, Tex.). In addition, a microtip pressure transducer was inserted into the left femoral artery, the tip was positioned at the origin of the femoral artery at the aorta, and the phase lag between the pressure signal in the aortic arch and the pressure signal in the femoral artery was measured. After monitoring arterial blood pressure and the aortic femoral delay time, the transducer was advanced into the left ventricle for the evaluation of left ventricular pressures and dP/dt. An additional microtip pressure transducer with a 1200 curved tip was inserted in the right jugular vein and advanced through the superior vena cava and the right atrium into the right ventricular chamber for the measurements of right ventricular pressures and dP/dt. Thus, measurements were made of systemic and ventricular pressures and dP/dt in the closed-chest preparation. At the end of the hemodynamic determinations, the heart was rapidly excised and immersed in ice-cold Tyrode's solution.
Measurement of the Degree of Coronary Artery Constriction
In each heart, the initial 2-3-mm segment of the left coronary artery was dissected free and cut transversely to expose the lumen of the coronary artery at the region of the ligature. The luminal diameters of the proximal portion of the vessel adjacent to the narrowed site and at the constricted region were measured by a dissecting microscope with an incorporated ocular reticle. Maximal and minimal internal diameters in each of these two locations were determined at a magnification of x20, and the geometric mean was calculated. Myofibrils were isolated and purified with Triton X-100. 21 In some of the myofibrillar preparations, the proteolytic enzyme inhibitors PMSF (0.2 mM), leupeptin (1 gtg/ml), pepstatin (1 gug/ml), and TLCK (0.1 mM) were used. To check the purity of the myofibrils by electrophoresis, the modified method of Maizel22 was used. The samples were run on sodium dodecyl sulfate gradient (5-16.5%) slab gel electrophoresis in a Tris-glycine buffer system. Contaminant proteins or evidence of proteolytic breakdown were not detected in these purified myofibrillar preparations.
Cardiac myofibrillar ATPase activities were assayed in a final volume of 1 ml at 30°C in a medium containing (mM) KCI which was used to determine the number of lesions represented by foci of damage per unit area of myocardium. The fraction of points lying over these foci was measured to compute the volume fraction of lesions in the myocardium and the cross-sectional area of the lesion profiles. Moreover, the relative volume of interstitial fibrosis in otherwise normal myocardium was analyzed by counting the number of points superimposed on this tissue component. This determination was also performed at x400 magnification in an identical number of fields used for evaluating lesion volume percent, size, and distribution. The foci of cell loss and replacement fibrosis all constituted myocardial lesions, since they were strictly related, representing different phases of evolution of the same process (i.e., replacement fibrosis takes place as a consequence of myocyte loss). Moreover, there is no demonstration so far that these areas of collagen accumulation with fibroblast infiltration, vessel proliferation, and inflammatory cells occur independent of myocyte loss. Although interstitial fibrosis (i.e., expansion of the extracellular compartment between myocytes) may develop independent of myocyte loss, no demonstration of such an effect has been provided yet. However, to avoid potential confusion between these two events, replacement fibrosis and interstitial fibrosis were evaluated separately in this investigation.
Data Collection and Analysis
All data were collected blindly, and the code was broken at the end of the experiment. Results are presented as mean±+SD computed from the average measurements obtained from each rat. Statistical significance in multiple comparisons among independent groups of data in which analysis of variance and the F test indicated the presence of significant differences was determined by Scheffe's method.27 Values ofp<0.05 were considered to be significant. Because measurements presented could not all be obtained in every rat and because samples were pooled at times, n values for each determination are given in the text.
Results

Coronary Constriction and Group Subdivision
The experimental procedure resulted in a range of degrees of constriction of the luminal diameter of the left coronary artery. Similarly, physiological measurements of global cardiac performance indicated different magnitudes of depressed ventricular function involving, at times, changes in left ventricular enddiastolic pressure (LVEDP) only and, in other instances, additional changes in +dP/dt and/or -dP/dt or right ventricular end-diastolic pressure (RVEDP). In this regard, arbitrary criteria were established to separate the 25 rats with coronary artery narrowing into three groups of 10, 9, and 6 rats, respectively. Hemodynamic parameters in sham-operated controls were used as a reference point for the generation of the groups, assuming that a specific measurement was altered when its value in an individual experimental rat was at least 1.5 x SD above or below the average of the corresponding determination in control rats. The first group (n = 10) included rats in which only LVEDP was affected; the second group (n=9) included rats in which not only LVEDP was abnormal but also left ventricular +dP/dt and/or -dP/dt were impaired; and the third group (n=6) included rats in which LVEDP, left ventricular + dP/dt and -dP/dt, and RVEDP were compromised. These groups were considered to represent left ventricular moderate dysfunction (MD), left ventricular severe dysfunction (SD), and left ventricular failure (LVF), respectively. As a result of this subdivision, the extent of coronary artery narrowing was found to be 64+18%, 56+21%, and 54±20%, respectively (p =NS).
Gross Cardiac Characteristics Table 1 illustrates the effects of coronary artery constriction on body weight and on the weights of the heart and its major subdivisions. Although the weights of the heart, left ventricle, and right ventricle tended to be greater in experimental rats than in control rats, only some of the changes seen were found to be statistically significant. In particular, heart weight, left ventricular weight, and right ventricular weight increased 18% (p<0.01), 12% (p<0.05), and 40% (pc0.01), respectively, in SD rats. Moreover, in the LVF group, right ventricular weight was 55% (p<0.001) and 36% (p<0.02) greater than that in control rats and in MD rats, respectively.
Since body weight was comparable in the different rat groups, a similar pattern was observed in the ratios of heart weight/body weight, left ventricular weight/body weight, and right ventricular weight/ body weight. The heart weight/body weight ratio was 2.71±0.22 mg/g in the control group, 2.88±0. 20 (data not shown). In contrast, combined left and right lung weight was 22% (p<0.001), 23% (p<0.001), and 42% (p<0.0001) greater in MD rats (1.81±0.14 g), SD rats (1.82±0.12 g), and LVF rats (2.10±0.25 g), respectively, than in control rats (1.48±0.14 g). In addition, lung weight in the failing group was 16% (p<0.01) and 15% (p<0.02) higher than in MD rats and SD rats, respectively. In summary, coronary constriction resulted in cardiac hypertrophy documented by elevations in weight of the left and right ventricles, which led to a statistically significant increase in heart weight/body weight ratio in SD and LVF rats. Ventricular Hemodynamics Table 1 illustrates the measurements of aorticfemoral delay time and systemic blood pressures in control and coronary-constricted rats. A 33% increase in aortic-femoral delay time was measured in the LVF group with respect to sham-operated control rats and MD and SD rats (p<0.0001). Although the blood pressure parameters were reduced in the three experimental groups, these changes were found to be statistically significant only in the SD group. In comparison with sham-operated control rats, diastolic, systolic, and mean arterial pressures in the SD group were decreased 26% (p<0.01), 22% (p<0.005), and 24% (p <0.05), respectively. Heart rate was not altered by coronary artery narrowing, and similar values were found in the four groups of rats ( In summary, chronic coronary artery constriction was associated with impairment of left ventricular function ranging from moderate dysfunction to overt failure.
Myocardial Damage
Light microscopic analysis of plastic embedded tissue sections demonstrated that coronary narrowing was frequently accompanied by multiple sites of myocardial damage that consisted of acute, subacute, and chronic lesions (Figures 1 and 2) . In sham-operated rats the myocardium showed normally appearing muscle cells and rare areas of injury ( Figure 1, top panel) . However, in coronary-constricted rats, foci of single ( Figure 1, bottom panel) or, at most, five myocyte profiles undergoing acute myocytolytic necrosis were frequently observed. Moreover, areas were seen in which myocytes were lost in discrete clusters and reparative processes were taking place. These subacute lesions showed no residual fragments of muscle cells and were characterized by vessel proliferation, inflammatory mononucleated cell infiltration, and the presence of numerous fibroblasts with initial collagen deposition (Figure 2, top panel) . Moreover, a more chronic stage in the evolution of replacement fibrosis was found. This feature consisted of areas of collagen accumulation surrounding small atrophic myocytes. Large fibroblasts dispersed within collagen were also present ( Figure 2, bottom panel) . Figures 3-5 illustrate the quantitative analysis of the volume percent, cross-sectional area, and numerical density of lesion profiles in the myocardium and their distribution across the ventricular wall. In spite of the different forms of tissue damage described above, the various lesions were combined in these morphometric determinations. They were representative of the same process, simply in distinct phases of evolution, from acute myocyte death to complete replacement fibrosis. Figure 3 shows that coronary constriction produced a 4.72-fold (p<0.0001), 4.40-fold (p<0.0001), and 8.33-fold (p<0.0001) increase in the number of lesions per square millimeter of endomyocardium in MD rats, SD rats, and LVF rats, respectively. Moreover, the value in the LVF group was significantly greater than that in the other two experimental groups. A similar pattern was seen in the midmyocardium and epimyocardium, although smaller differences among the groups were noted in these two regions of the ventricular wall. When the data in the separate layers were combined to yield average values across the wall, increases of 3.31-fold (p<0.0001), 3.14-fold (p<0.001), and 5.13-fold (p<O.OOOl) were measured in the MD, SD, and LVF rats, respectively. In addition, the size of these lesion profiles ( Figure 4 ) and the volume fraction of myocardial damage in the ventricle ( Figure 5) were greater in the LVF group.
The changes in the volume fraction of interstitial fibrosis associated with coronary artery narrowing are illustrated in Figure 6 . Interstitial fibrosis increased consistently in each layer of the left ventricular wall of all rats. However, this alteration was more apparent in MD rats, followed by LVF rats, and last by SD rats.
In summary, chronic coronary artery constriction led to an ongoing process characterized by the continuous generation of foci of myocardial damage, which was enhanced in the presence of ventricular failure. Interstitial fibrosis, however, was prominent with moderate dysfunction.
Contractile Protein Biochemistry
The Ca2'-dependent activities of myofibrillar Mg2`-ATPase activity in the left ventricle with increasing free Ca' concentration (from 10`8 to 10`4 M) are shown in Figure 7 . A fourth-order linear regression analysis was performed to construct the curves depicted in Figures 7 and 8 . Figure 7A illus Figure 7 . Although Mg2 -ATPase activity appeared higher in this group than in the control group throughout the different ranges of calcium concentration (Figure 7B) , the difference from baseline was of smaller magnitude than that found with the MD group. With EGTA, ATPase activity was 1.52-fold greater in experimental than in sham-operated rats (control, 0.046±t-0.013 gM P/m/ mg; SD, 0.070+0.020 gM P/im/mg;p<0.01) and not significantly greater with 4.5 pCa (control, 0.181±0.021 gM Pi/m/rg; SD, 0.196-0.031 gM P,/m/rng; p=NS). When failure occurred, myofibrillar ATPase activity was essentially similar to that of controls, and no statistically significant variation could be detected in the presence of EGTA or at any free Ca21 concentration used ( Figure 7C ).
The changes in myofibrillar ATPase activity in the right ventricular myocardium are depicted in Figure  8 . In a manner that paralleled the response of the left ventricle, Mg-ATPase activity at different free Ca>2 concentrations was consistently higher in MD or SD rats ( Figures 8A and 8B ). However, differences were almost completely abolished by the appearance of left ventricular failure ( Figure 8C Figure 9A shows that Ca2' myosin ATPase activity in the left ventricle decreased by 17% (p <0.06), 28% (p<0.005), and 29% (p<0.01) in MD rats, SD rats, and LVF rats, respectively. In contrast, Ca21 myosin ATPase activity in the right ventricle increased 20% (p<0.03) in the SD group, whereas it was not significantly different from control values in the other two groups of rats subjected to coronary artery stenosis ( Figure 9B ). However, no intergroup difference was seen among rats in spite of variations in the hemodynamic profile.
The percent content of myosin isoenzymes demonstrated that the V1 isomyosin fraction decreased in the left ventricle after coronary narrowing (control, 94+5.0%; MD, 75±12.0%; SD, 82+15.0%; LVF, 88+5.0%). However, only the 20% reduction in rats with diastolic impairment was found to be statistically significant (p<0.01). The changes in the right myocardium were more consistent and similar in the three groups of coronary-narrowed rats (control, 85+5.0%; MD, 99+1.0%; SD 98+2.0%; LVF, 98±2.0%). The MD, SD, and LVF rats showed augmentations in V1 of 17% (p<0.0001), 15% (p<0.0001), and 18% (p<0.0001), respectively. Of relevance, the V1 isomyosin fraction reached 100% in the right ventricle of LVF rats. Although not illustrated, the adaptations in V3 were opposite those described for V1. Representative densitometric scans of polyacrylamide gels of the isoenzymic composition of myosin from the left ventricle are illustrated in Figure 10 . cardium V1 was either reduced or unaffected, an increase in the V1 isoenzyme fraction with a corresponding diminution of the V3 form was found in the right myocardium in all cases of coronary narrowing.
Ventticular Function
Results in this investigation demonstrate that comparable degrees of coronary artery stenosis produced variable changes in ventricular dynamics. At times, cardiac decompensation included only an elevation in LVEDP, or abnormalities in this parameter with a depressed +dP/dt and/or -dP/dt, or a combination of these with an increase in RVEDP. Therefore, coronary narrowing produced different magnitudes of impairment in left ventricular hemodynamics, from moderate dysfunction to severe dysfunction, and failure. The mechanisms responsible for the heterogeneity in the alterations of ventricular performance with coronary stenosis are currently unknown. However, consistent with the current findings, previous observations in this animal model have shown that similar vessel constrictions induce severe depressions in cardiac pump function acutely"1 and subacutely.12 Although resting coronary blood flow has been found to be maintained under these conditions,"11,2 coronary vascular reserve is affected in direct proportion to the magnitude of vessel stenosis.12 This abnormality in combination with the increased oxygen demand, dictated by global ventricular remodeling with chamber dilation, wall thinning, and increased wall stress,11 may create an imbalance between oxygen requirement and supply, leading to an impairment of cardiac dynamics and ventricular failure. Should this mechanism be operative, however, the implication is that the accepted belief (i.e., that myocardial ischemia and alterations in ventricular performance do not occur unless reductions of 75-80% in luminal diameter of a major epicardial artery are obtained28'29) has to be revised.
Observations on nonocclusive coronary artery constriction tend to suggest that sudden reductions in vessel lumen, even of modest degree, induce an impairment of ventricular hemodynamics that is immediate," persists during the subacute phase,12 and is still present chronically. The chronic effects have been demonstrated in this report 1 month after the surgical induction of coronary narrowing. However, the acute and short-term reactions have been remarkably similar with respect to the physiological characteristics of ventricular pump performance. 1"112 In both cases, left ventricular failure was consistently found with no indications of a heterogeneous adaptation among the various animals. On the other hand, in the current investigation, differences have been documented chronically in the magnitude and nature of ventricular deadaptation. Since the extent of coronary stenosis was comparable in these multiple studies, the absence of clear indexes of cardiac failure in more than two thirds of the rats 1 month after the operation points to the possibility that a partial recovery of function may have occurred after the initial severe depression in ventricular dynamics. The factors involved in this potential process are difficult to identify, although reactive growth mechanisms in myocytes may have contributed to compensate in part for the elevation in systolic and diastolic stress on the myocardium,1" improving ventricular contractile performance. Why differences in the hemodynamic profile are present in rats at 1 month is unclear, but a similar variability has repeatedly been claimed in humans. [5] [6] [7] Myocardial Damage and Cardiac Hypertrophy
The current results demonstrate that prolonged coronary artery narrowing is associated with multiple foci of tissue and myocyte injury in the ventricular myocardium. Acute myocytolytic necrosis was found in combination with sites of replacement fibrosis in distinct phases of healing. Quantitatively, the number of lesions per unit area of myocardium, size of lesion profiles, and volume percent of lesions in the tissue were similar in MD and SD rats, whereas significantly greater values in these morphometric parameters were demonstrated in LVF rats. In contrast, interstitial fibrosis appeared to prevail in MD rats, although differences among the groups could not be clearly demonstrated. In all cases, structural damage affected the endomyocardium more than the midmyocardium and epimyocardium. Moreover, in spite of tissue injury, heart weight and the weight of the left and right ventricles were either preserved or increased.
Two important implications arise from these observations: 1) A fixed reduction in caliber of the left main coronary artery leads to a conditioned state of the heart characterized by chronic loss of myocytes and ongoing reparative processes with collagen accumulation. 2) Reactive hypertrophy occurs in the unaffected myocardium in an attempt to compensate for the increase in load generated by the loss of muscle cells and the altered hemodynamic state. The etiologic mechanism responsible for the chronic loss of myocytes is currently unknown. Previous investigations aiming to establish whether myocardial ischemia played a primary role in the genesis of tissue and cellular injury have failed to document any appreciable decrease in resting coronary blood flow to the myocardium.11""2 Importantly, coronary perfusion at rest has to be reduced to -25-50% of its control value to produce irreversible myocardial injury, ischemic in origin.30 Moreover, the possibility of platelet aggregation at the region of constriction of the coronary artery,31 with the formation of minute emboli occluding small-sized arteries and arterioles, is not consistent with the discrete nature of the structural damage. A similar limitation applies to the potential of vasospastic reactive responses of the coronary artery. Myocytolytic necrosis was restricted to one to five myocytes, whereas embolic occlusion and/or spasm of coronary resistance vessels would involve ischemic necrosis of nearly 1,000 muscle cells.32 It cannot be excluded, however, that alterations at the capillary level of tissue organization may have altered the oxygenation potential locally implementing cell injury. On the other hand, there is no documentation yet that reductions in capillary luminal surface and volume, increases in diffusion distance for oxygen, and heterogeneity in capillary spacing may lead to myocytolytic necrosis and focal cell loss.
In view of the difficulty in reconciling the characteristics of tissue and myocyte injury with alterations in coronary blood flow and/or vasomotor tone of the intramural branches of the coronary circulation, other potential factors such as mechanical1"12 or catecholamine-induced33 cell death have to be considered. Although the etiology of myocytolytic necrosis in this model is still unclear, damage is an early event," progresses with time,12 and continues to occur chronically. Of relevance, the presence of ventricular failure at 1 month was associated with a greater extent of tissue injury than shortly after coronary occlusion,12 in spite of similar levels of coronary stenosis and impairment of function. On this basis, it can be suggested that, after an initial recovery in ventricular dynamics, the magnitude of cell loss might have become critical for adequate ventricular performance. This phenomenon has repeatedly been observed in different cardiomyopathies and after myocardial infarction.34
Data in the current study suggest that a significant hypertrophic tissue response occurred in the left ventricle of coronary-constricted rats in association with moderate dysfunction, severe dysfunction, and ventricular failure. However, the process of myocyte loss complicates the evaluation of the magnitude of tissue growth at the organ level.35,36 Weight measurements alone result in a significant underestimation of the extent of hypertrophy in the unaffected myocytes, which is proportional to the degree of cell death in the myocardium. The impossibility of determining the changes in myocyte size and number in immersed fixed tissue precluded the accurate assessment of hypertrophy in coronary-narrowed hearts. However, similar ventricular weights were found in the three experimental rat groups, implying that the greater destruction in muscle mass in the LVF rats was paralleled by a greater growth reaction in the remaining viable cells. More obscure is the basis for right ventricular hypertrophy. The increase in lung weight in chronic narrowing would suggest a pressure-overload state on the right side of the heart. However, the lack of an increase in right ventricular systolic pressure challenges this possibility. Whether The abnormalities in myofibrillar Mg2'-ATPase that develop with coronary artery stenosis are difficult to explain and correlate with the physiological characteristics of cardiac pump performance. The heterogeneity in the response of the myocardium observed in terms of hemodynamic properties and structural damage was also apparent with respect to myosin ATPase activity, further documenting that comparable degrees of coronary narrowing led to a wide range of biochemical, functional, and morphological alterations. The upward shift in the myofibrillar calcium dose-response curve found in MD and SD rats raises the possibility that increased levels of Mg2+-ATPase activity would cause greater ATP use and oxygen demand in hearts where coronary reserve has been shown to be compromised.12 Moreover, the elevated Mg2+-ATPase with EGTA may be in part responsible for the elevation in LVEDP, since enhanced enzymatic activity under these conditions may imply abnormalities in the relaxation behavior of the muscle. However, the identical phenomenon in the right ventricle, a more compliant structure, was not associated with an increase in RVEDP.
The differential adaptation between the two ventricles may reflect the changes in Ca21 myosin The etiology of the change in calcium sensitivity of cardiac myofibrillar Mg2+-ATPase after coronary constriction is difficult to recognize at present. However, the shape of the sigmoid curve at different free calcium concentrations was consistently maintained, indicating that the sensitivity of the myofibrillar assembly to calcium was preserved in experimental rats. Thus, the changes in the properties of myofibrils from rats with coronary stenosis appear to be independent from calcium ion concentration. Most likely, the altered basal Mg2+-ATPase activity may be related to an abnormality in the troponin-tropomyosin system, a condition recently documented in genetically determined cardiomyopathy43,44 and during postnatal development of the heart.45-47 The implication is a defect in the capacity of troponin I to inhibit actin and myosin interaction in the absence of Ca'+. Moreover, thyroid hormone levels have been shown to affect these regulatory proteins and the characteristics of the sensitivity to calcium of myofibrillar preparations. 48 The effects of coronary constriction on Ca2+ myosin ATPase activity were not comparable in the two ventricles, contrasting the observations on myofibrillar Mg-ATPase discussed above. However, consistent with previous findings in myocardial aging,49 hypertensive cardiomyopathy,17 and myopathic Syrian hamsters,18 the depressed contractile performance of the left ventricular myocardium in rats with coronary stenosis was associated with a reduction in myosin Ca2+-ATPase. On the other hand, the hypertrophied right myocardium with preserved or moderately impaired ventricular dynamics was characterized by normal or elevated myosin Ca2+-ATPase.
The relative distribution of myosin isoenzymes changed differently in the two ventricles. Whereas in the left ventricle there was a consistent reduction of the predominant V1 isoform and an increase in the slow migrating V3 isoenzyme, in the right ventricle the V1 isoform augmented significantly in all cases, reaching 100% in the LVF rats. Since it has been repeatedly shown that the unloaded speed of muscle shortening correlates with Ca2' myosin ATPase activity and the amount of V1 present,505' coronary constriction produced biochemical alterations that may have resulted in a depressed mechanical performance of the left myocardium and an enhanced contractile behavior of the right myocardium. These distinct effects may also explain the differences in LVEDP and RVEDP in spite of comparable upward shifts in the calcium dose-response curve of myofibrillar Mg2`-ATPase found in coronary-narrowed rats.
In conclusion, a fixed nonocclusive lesion of the left main coronary artery, modest in magnitude, resulted in impairment in ventricular hemodynamics, myocardial damage, and abnormalities in contractile protein enzyme activity that differed in severity independent from the extent of coronary artery narrowing. Although the amount of tissue injury correlated with the depression in myocardial contractile performance, the biochemical changes returned to normal in association with ventricular failure. Whether the observations of various degrees of myocardial dysfunction, tissue injury, and altered biochemistry imply that the process is progressive in nature requires further investigation.
